Selected publications (below) from the core investigators of the center reflect the wide range of the center’s research capacity:


1. Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 Mar;109(3):434-436. Epub 2019 Jan 24.

2. Borden BA, Lee SM, Danahey K, Galecki P, Patrick-Miller L, Siegler M, Sorrentino MJ, Sacro Y, Davis AM, Rubin DT, Lipstreuer K, Polonsky TS, Nanda R, Harper WR, Koyner JL, Burnet DL, Stadler WM, Kavitt RT, Meltzer DO, Ratain MJ, O’Donnell PH. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 Feb 11. [Epub ahead of print]

3.Spitzer-Shohat S, Chin MH. The “Waze” of Inequity Reduction Frameworks for Organizations: a Scoping Review. J Gen Intern Med. 2019 Feb 7. [Epub ahead of print]

4. Pollack HA. The Responsibility to Advocate-and to Advocate Responsibly. Milbank Q. 2019 Jan 21. [Epub ahead of print]

5. Graham AK, Minc A, Staab E, Beiser DG, Gibbons RD, Laiteerapong N. Validation of the Computerized Adaptive Test for Mental Health in Primary Care. Ann Fam Med. 2019 Jan;17(1):23-30.


1. Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O’Grady M, Huang ES. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 2018 Nov;38(8):942-953.

2. Tung EL, Johnson TA, O’Neal Y, Steenes AM, Caraballo G, Peek ME. Experiences of Community Violence Among Adults with Chronic Conditions: Qualitative Findings from Chicago. J Gen Intern Med. 2018 Nov;33(11):1913-1920. Epub 2018 Aug 3.

3. Tung EL, Gunter KE, Bergeron NQ, Lindau ST, Chin MH, Peek ME. Cross-Sector Collaboration in the High-Poverty Setting: Qualitative Results from a Community-Based Diabetes Intervention. Health Serv Res. 2018 Oct;53(5):3416-3436. Epub 2018 Jan 22.

4. Hantel A, Levine S, Siegler M. Creating Coherent Strategies to Combat the Crises of Opioid Scarcity and Abuse. J Clin Oncol. 2018 Sep 1;36(25):2575-2577.

5. Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, Karter AJ. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (the Diabetes & Aging Study). Diabetes Care. 2018 Aug 13. [Epub ahead of print]

6. Andrews CM, Grogan CM, Smith BT, Abraham AJ, Pollack HA, Humphreys K, Westlake MA, Friedmann PD. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health Aff (Millwood). 2018 Aug;37(8):1216-1222.

7. Pozdnyakova A, Laiteerapong N, Volerman A, Feld LD, Wan W, Burnet DL, Lee WW. Impact of Medical Scribes on Physician and Patient Satisfaction in Primary Care. J Gen Intern Med. 2018 Jul;33(7):1109-1115. Epub 2018 Apr 26.

8. Laiteerapong N, Cooper JM, Skandari MR, Clarke PM, Winn AN, Naylor RN, Huang ES.  Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 Feb 6;168(3):170-178. Epub 2017 Dec 12.

9. Brennan MB, Huang ES, Lobo JM, Kang H, Guihan M, Basu A, Sohn MW. Longitudinal trends and predictors of statin use among patients with diabetes. J Diabetes Complications. 2018 Jan;32(1):27-33.

10. Lee AK, Warren B, Lee CJ, McEvoy JW, Matsushita K, Huang ES, Sharrett AR, Coresh J, Selvin E. The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes. Diabetes Care. 2018 Jan;41(1):104-111.

To view more publications by our Center’s researchers, click here.